Target
Transmembrane and immunoglobulin domain-containing 3
Ligand
BDBM50654
Substrate
n/a
Ki
>10000±n/a nM
Comments
PDSP_2570
Citation
 van Galen, PJvan Bergen, AHGallo-Rodriguez, CMelman, NOlah, MEIJzerman, APStiles, GLJacobson, KA A binding site model and structure-activity relationships for the rat A3 adenosine receptor. Mol Pharmacol 45:1101-11 (1994) [PubMed] 
Target
Name:
Transmembrane and immunoglobulin domain-containing 3
Synonyms:
ADENOSINE A3 | ADORA3 | Adora3 protein
Type:
Enzyme Catalytic Domain
Mol. Mass.:
25707.75
Organism:
RAT
Description:
Q4V8H0
Residue:
232
Sequence:
MEPLLLLSLALFSDAMVMDEKVKSGVELDTASAICNYDAHYKDHTKYWCRGYFRDSCNIIAFTPNSSNRVALKDTGDQLIITVSCLVKEDTGWYWCGIQRDFARDDMDFTKLIVTDNREDRANGLSPGTSGNRTRSCKTSKAVQKAEGSRMSILIVCVLISGLGIIFLISHMSRGRRSQRNRGVTGKSINRNPQASQAPSMVSIPLTVLPKVPRQNGQQKALQWTGNATKTG
  
Inhibitor
Name:
BDBM50654
Synonyms:
2-amino-9-(3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl)-3H-purine-6-thione | 2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-3H-purine-6-thione | 2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-6-thione | 2-azanyl-9-[5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]-3H-purine-6-thione | 6-Thioguanosine | 9H-Purine-6-thiol, 2-amino-9-.beta.-D-arabinofuranosyl-, hydrate (4:1) | MLS000738229 | SMR000528588 | cid_3938248
Type:
Small organic molecule
Emp. Form.:
C10H13N5O4S
Mol. Mass.:
299.306
SMILES:
Nc1nc2n(cnc2c(=S)[nH]1)C1OC(CO)C(O)C1O
Structure:
Search PDB for entries with ligand similarity: